Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - Elsevier
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age

JA Crippa, FS Guimarães, AC Campos… - Frontiers in …, 2018 - frontiersin.org
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a
compound that does not produce the typical subjective effects of marijuana. Objectives: The …

Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets

J Zhang, W Yao, K Hashimoto - Current neuropharmacology, 2016 - ingentaconnect.com
Depression is the most prevalent and among the most debilitating of psychiatric disorders.
The precise neurobiology of this illness is unknown. Several lines of evidence suggest that …

Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a …

A de Bartolomeis, A Barone, L Vellucci, B Mazza… - Molecular …, 2022 - Springer
Evidence from clinical, preclinical, and post-mortem studies supports the
inflammatory/immune hypothesis of schizophrenia pathogenesis. Less evident is the link …

Altering the course of schizophrenia: progress and perspectives

MJ Millan, A Andrieux, G Bartzokis… - Nature reviews Drug …, 2016 - nature.com
Despite a lack of recent progress in the treatment of schizophrenia, our understanding of its
genetic and environmental causes has considerably improved, and their relationship to …

An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

N Çakici, NJM Van Beveren, G Judge-Hundal… - Psychological …, 2019 - cambridge.org
BackgroundAccumulating evidence shows that a propensity towards a pro-inflammatory
status in the brain plays an important role in schizophrenia. Anti-inflammatory drugs might …

Microglia: immune regulators of neurodevelopment

M Cowan, WA Petri Jr - Frontiers in immunology, 2018 - frontiersin.org
Microglia, the tissue-resident macrophages of the central nervous system (CNS), have
characterized roles in combating infection, clearing cellular debris, and maintaining tissue …

Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment

D Mattei, A Ivanov, C Ferrai, P Jordan… - Translational …, 2017 - nature.com
Maternal immune activation (MIA) during pregnancy has been linked to an increased risk of
developing psychiatric pathologies in later life. This link may be bridged by a defective …

Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia

E Parellada, P Gassó - Translational psychiatry, 2021 - nature.com
Schizophrenia disorder remains an unsolved puzzle. However, the integration of recent
findings from genetics, molecular biology, neuroimaging, animal models and translational …

Minocycline in neurodegenerative and psychiatric diseases: an update

D Romero‐Miguel, N Lamanna‐Rama… - European Journal of …, 2021 - Wiley Online Library
Background and purpose Minocycline is a broad‐spectrum antibiotic, effective as a chronic
treatment for recurrent bacterial infections. Beyond its antibiotic action, minocycline also has …